Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-11-08
1995-06-27
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514365, 514374, 514375, 548131, 548205, 548222, 548235, A61K 31415, A61K 3142, A61K 31425, C07D26332
Patent
active
054280486
ABSTRACT:
This invention relates to compounds which inhibit lipoxygenase in the metabolism of arachidonic acid and thus inhibits formation of leukotrienes which are implicated in inflammatory processes and bronchoconstriction and inhibits the oxidation of LDL which is implicated in formation of atherosclerotic plaque.
The compounds useful in this invention are represented by the formula: ##STR1## wherein: R.sup.2 is hydrogen, halogen or C.sub.1 -C.sub.6 alkyl; Y of O or S; R.sup.5 is hydrogen or methyl R.sup.6 is --NH.sub.2, --CH.sub.3 or --OCH.sub.3 ;
REFERENCES:
Reaven et al., Arteriosclerosis and Thrombosis 12(3), 318-21 (1992).
Steinberg, Amer J. of Cardiology 57, 16H-21H, (1986).
Carew, Schwenke and Steinberg, Proc. Natl. Acad. Sci. 84, 7725-29 (1987).
Nagano et al., Arteriosclerosis 9(4), 453-461 (1989).
Moskowitz, Medline Abs. #91080793, 1991.
Gunawan Iwan
Malamas Michael S.
American Home Products Corporation
Boswell, Jr. R. F.
Cebulak Mary C.
Hollrah Glennon H.
LandOfFree
Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-art does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-art, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-art will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-287823